RIVAROXABAN

UNII:	9NDF7JZ4M3
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₉H₁₈ClN₃O₅S
Preferred Substance Name:	RIVAROXABAN
InChIKey:	KGFYHTZWPPHNLQ-AWEZNQCLSA-N
GSRS Full Record:	9NDF7JZ4M3 i

366789-02-8
(S)-Rivaroxaban
2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-
5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide
5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
BAY-59-7939
BAY59-7939
JNJ-39039039
JNJ39039039
Rivaroxaban
Rivaroxaban [EMA EPAR]
Rivaroxaban [EP MONOGRAPH]
Rivaroxaban [INN]
Rivaroxaban [JAN]
Rivaroxaban [MART.]
Rivaroxaban [MI]
Rivaroxaban [ORANGE BOOK]
Rivaroxaban [USAN]
Rivaroxaban [USP-RS]
Rivaroxaban [VANDF]
Rivaroxaban [WHO-DD]
XARELTO

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RIVAROXABAN

Synonyms and Mappings

Resources